Kenvue’s Weak Sales Give Power to Activist Push

Published on 8 Nov 2024 on The Business of Fashion

Kenvue’s Weak Sales Give Power to Activist Push

Kenvue Inc., the owner of Tylenol and Neutrogena, reported sales that trailed estimates after its skin health and beauty category slowed. Organic sales...

Read the rest of the article

NYSE.KVUE price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Should SPDR Portfolio S&P 500 High Dividend ETF (SPYD) Be on Your Investing...

And, most ETFs are very transparent products that... (K) accounts for about 1.65% of total assets...

Zacks · via Yahoo Finance 19 Nov 2024

Is Broadcom Inc. (AVGO) the Best Predictive Analytics Stock to Invest in Now?

We recently published a list of 10 Best Predictive Analytics Stocks to Invest in Now. In this...

Insider Monkey · via Yahoo Finance 16 Nov 2024

Crossmark Global Holdings Inc. Has $1.32 Million Stake in Kenvue Inc....

Crossmark Global Holdings Inc. grew its position in Kenvue Inc. (NYSE:KVUE – Free Report) by 8.1%...

ETF DAILY NEWS 14 Nov 2024

Venturi Wealth Management LLC Grows Holdings in Kenvue Inc. (NYSE:KVUE)

Venturi Wealth Management LLC raised its position in Kenvue Inc. (NYSE:KVUE – Free Report) by 100...

ETF DAILY NEWS 14 Nov 2024

FDA Wants To Pull Popular OTC Decongestant Used For Common Cold Over...

On Thursday, the FDA proposed removing oral phenylephrine from the list of approved active...

Benzinga · via Yahoo Finance 9 Nov 2024

Kenvue’s Weak Sales Give Power to Activist Push

Kenvue Inc., the owner of Tylenol and Neutrogena, reported sales that trailed estimates after its...

The Business of Fashion 8 Nov 2024

Kenvue Inc. (KVUE): Expanded Production and Trusted Brands Drive Growth

We recently published a list of 8 Best Consumer Staples Stocks To Buy Right Now. In this article,...

Insider Monkey · via Yahoo Finance 8 Nov 2024

Listerine And Tylenol Maker Kenvue's Q3 Earnings: Revenue Miss On Weak Skin...

Consumer health company Kenvue Inc. (NYSE:KVUE) reported third-quarter sales of $3.89 billion, do...

Benzinga · via Yahoo Finance 8 Nov 2024

Kenvue's Double Catalysts: Starboard Stake and Dividend Announcement

Kenvue has a formidable lineup of well-known consumer health brands, such as Aveeno, Tylenol,...

GuruFocus.com · via Yahoo Finance 22 Oct 2024

Starboard says Kenvue's skin health segment is weighing on performance

, opens new tab a bargain and said its skin health and beauty segment's lackluster growth is the...

Reuters 22 Oct 2024

News

Kenvue’s Weak Sales Give Power to Activist Push

NYSE.KVUE price evolution

Want to become a better investor?